Price
CHART BY
Frequently asked questions
What is ASP Isotopes's market capitalization?
What is the Earnings Per Share (EPS) for ASP Isotopes?
What are the analyst ratings and target price for ASP Isotopes's stock?
What is ASP Isotopes's revenue over the trailing twelve months?
What is the EBITDA for ASP Isotopes?
What is the free cash flow of ASP Isotopes?
How many employees does ASP Isotopes have, and what sector and industry does it belong to?
What is the free float of ASP Isotopes's shares?
Financials
- Market Cap
- $979.53M
- EPS (TTM)
- -$2.071
- Free Float
- 112.95M
- Revenue (TTM)
- $26.93M
- EBITDA (TTM)
- -$68.99M
- Free Cashflow (TTM)
- -$65.80M
Pricing
- 1D span
- $7.944$8.093
- 52W span
- $3.93$14.48
Analyst Ratings
The price target is $13.00 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.
- Employees
- 271
- Industries
- Major Pharmaceuticals
- Sector
- Industrials
Identifier
- Primary Ticker
- ASPI